Every rare disease is, by definition, uncommon. Taken together, they are not. An estimated 300 million people worldwide live with one, which is more than the population of most countries. Yet many of them spend years searching for a name for what is wrong, and most will never have a treatment designed for their condition. Rare Disease Day, observed on the last day of February, exists to turn that scattered, private struggle into a shared public concern. It asks a simple question: if the patients are so many, why does the system treat them as so few?
How a small campaign became a movement
Rare Disease Day was launched in 2008, when events were held in just 18 countries. It is coordinated by EURORDIS, the European rare disease patient alliance, together with national alliances and patient organizations. Today it is observed in more than 100 countries, and national alliances in 77 countries help coordinate it. The date is the last day of February, so it falls on February 28 in most years and on February 29 in leap years. In 2027, it is February 28.
The day began with patients, not governments, and that origin still shapes it. Later, institutions followed. In 2021 the UN General Assembly adopted resolution 76/132 on addressing the challenges of persons living with a rare disease and their families. In May 2025 the World Health Assembly adopted resolution WHA78.11, titled “Rare diseases: a global health priority for equity and inclusion.” The 2026 campaign message, “More Than You Can Imagine,” calls on people to recognize both the scale of the community and the progress that is possible when barriers to diagnosis, treatment, research and participation are removed.
What “rare” really means
There is no single worldwide definition. The text of WHA78.11 describes a rare disease as a condition affecting fewer than 1 in 2,000 people in the general population. Counting conditions that meet such thresholds, EURORDIS reports more than 6,000 distinct rare diseases, while the Assembly resolution cites more than 7,000 known ones. The totals differ because lists and definitions differ, and new conditions keep being described.
The paradox is in the arithmetic. Each disease is rare, yet together they affect an estimated 300 million people, or between 3.5 and 5.9 percent of the world’s population. In Europe alone, EURORDIS estimates 30 million people in 48 countries live with a rare disease. Rare does not mean unusual in the aggregate. It means that each patient is scattered, and that few doctors will ever see the same condition twice.
Example 1: a city’s hidden community. Picture a city of 1,000,000 people. Using the 3.5 to 5.9 percent range, between 35,000 and 59,000 residents would live with a rare disease. The city is illustrative and the numbers are round, but the point is real: a population that size would fill a stadium, yet each of its members may feel alone.
The numbers behind the day
Rare diseases are mostly written in the genes and most begin early in life. Seventy-two percent are genetic and around 70 percent present in childhood, according to Rare Disease Day. One in five cancers is classified as rare, which links this day to International Childhood Cancer Day. Among the grimmest figures is the one in the 2025 Assembly resolution: more than 95 percent of rare diseases still lack an effective treatment.
- 300 millionpeople live with a rare disease worldwide, an estimate
- 6,000+distinct rare diseases, by EURORDIS count
- 30 millionpeople affected across 48 countries in Europe
- 1,200diseases with more than five documented cases in the scientific literature, per EURORDIS
The long road to a name
For a patient, the hardest part is often the start. A Rare Barometer survey fielded in 2022 reached 6,507 people in 41 countries in geographical Europe and found an average time to diagnosis of 4.7 years. It also found that 56 percent of respondents were diagnosed more than six months after their first medical contact. EURORDIS adds, from its Rare Barometer surveys, that 70 percent wait more than a year for a confirmed diagnosis and that 44 percent consult more than four health professionals first. The WHO resolution agrees that reaching the correct diagnosis can take more than five years.
Example 2: five years of waiting. Imagine a child who develops symptoms at age 6 and is diagnosed at 11, close to the average. During those years the family visits many clinics, tries treatments for the wrong problem and keeps no name for what to ask about. The numbers are round and illustrative, yet they show why earlier diagnosis, including newborn screening, is a priority in the Assembly resolution.
Why it matters beyond the clinic
A late diagnosis is more than an inconvenience. It can mean delayed care, repeated tests, missed school and strained family finances. Because each disease is rare, research funds and commercial interest are scarce, and evidence is thin. That is why registries, shared data and international cooperation matter so much. WHA78.11 urges countries to integrate rare diseases into national health planning, including newborn screening, registries, health worker training and progress toward universal health coverage by 2030.
Treatment gaps run deep. In the European Union, EURORDIS counts over 230 authorized orphan medicines, a number that shows what incentives can do, yet it remains small next to thousands of conditions. Example 3: a treatment shortfall. Picture 100 rare conditions. If more than 95 lack an effective treatment, fewer than 5 have one. The group is illustrative, but the ratio is the one in the resolution.
What progress looks like next
The day is also a deadline. The World Health Assembly asked the WHO Director-General to prepare a 10-year draft global action plan for rare diseases, with adoption intended at the 81st Assembly in May 2028. According to WHO, a discussion paper was posted in November 2026, a first draft is due in early 2027, and consultations will follow. The next observance, on February 28, 2027, falls while those drafts are taking shape.
For ordinary people, the day offers simple actions. Learn how many people are affected. Listen to patients and caregivers. Support organizations that fund research or run registries. Teachers, nurses and doctors can ask a plain question when a pattern does not fit a textbook: what else could this be? Rare Disease Day does not promise cures. It promises that the people living with these conditions will be seen, counted and heard.
Key Takeaways
- Rare diseases are common in sum. An estimated 300 million people live with one, 3.5 to 5.9 percent of the world.
- Definitions vary. A common threshold is fewer than 1 in 2,000 people, and counts range from more than 6,000 to more than 7,000 diseases.
- Most are genetic and start young. Seventy-two percent are genetic and around 70 percent present in childhood.
- The diagnosis wait is long. A 2022 survey found an average of 4.7 years to a diagnosis.
- Treatment lags. More than 95 percent of rare diseases lack an effective treatment, according to the 2025 Assembly resolution.
- A global plan is underway. WHO is drafting a 10-year action plan, with adoption intended in May 2028.
How solid is this? The 300 million figure and the share of genetic and childhood-onset diseases are estimates from patient-alliance and Orphanet-based work, and disease counts differ by source. The diagnosis figures come from surveys of patients in Europe, not the whole world. The three worked examples use round, made-up numbers to show an idea. See also the International Days hub and the International Days Calendar.
More in Health
- Rare Disease Day. Rare Disease Day 2026 highlights global inequities and amplifies youth voices (February 2026).
- EURORDIS-Rare Diseases Europe. What is a rare disease?
- EURORDIS-Rare Diseases Europe. Diagnosis in rare diseases.
- Faye F, et al. Time to diagnosis and determinants of diagnostic delays of people living with a rare disease. European Journal of Human Genetics (2024).
- World Health Assembly. WHA78.11, Rare diseases: a global health priority for equity and inclusion (May 2025).
- World Health Organization. Global action plan on rare diseases: process and next steps (August 2026).
